Long term 5-year survival of persons with cryptococcal meningitis or asymptomatic subclinical antigenemia in Uganda.
about
HIV-Associated Cryptococcal Meningitis: Bridging the Gap Between Developed and Resource-Limited SettingsCryptococcal Meningitis Treatment Strategies Affected by the Explosive Cost of Flucytosine in the United States: A Cost-effectiveness AnalysisCryptococcal meningitis: epidemiology and therapeutic options.Predictors of neurocognitive outcomes on antiretroviral therapy after cryptococcal meningitis: a prospective cohort study.Neurocognitive function in HIV-infected persons with asymptomatic cryptococcal antigenemia: a comparison of three prospective cohortsPrevalence of cryptococcal infection among advanced HIV patients in Argentina using lateral flow immunoassay.Performance of cryptococcal antigen lateral flow assay using saliva in Ugandans with CD4 <100.Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis.AIDS-related mycoses: the way forward.Cryptococcal Antigenemia in Immunocompromised Human Immunodeficiency Virus Patients in Rural Tanzania: A Preventable Cause of Early Mortality.Cost-effectiveness of CRAG-LFA screening for cryptococcal meningitis among people living with HIV in Uganda.Cytokine patterns in a prospective cohort of HIV-infected patients with cryptococcal meningitis following initiation of antifungal and antiretroviral therapyHuman Immune Response Varies by the Degree of Relative Cryptococcal Antigen Shedding.Comparison of cryptococcal antigenemia between antiretroviral naïve and antiretroviral experienced HIV positive patients at two hospitals in Ethiopia.Asymptomatic cryptococcemia in resource-limited settings.The cryptococcal antigen lateral flow assay: A point-of-care diagnostic at an opportune time.Burden of serious fungal infections in Tanzania.Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis.Opportunistic Invasive Mycoses in AIDS: Cryptococcosis, Histoplasmosis, Coccidiodomycosis, and Talaromycosis.Cryptococcus: Shedding New Light on an Inveterate Yeast.Are fluconazole or sertraline dose adjustments necessary with concomitant rifampin?A Prospective Evaluation of a Multisite Cryptococcal Screening and Treatment Program in HIV Clinics in Uganda
P2860
Q28078958-D50DA11D-3219-466B-9BD2-6068415B1A12Q28274334-71796C2C-6733-4B1D-8CF8-0E6359334C03Q33633343-E4E825AD-29E2-427C-9B4B-BB6A18A6800FQ33663591-9CC81595-98C0-4973-AE4A-6865BCA11ECCQ33792332-DA8241C1-ED16-4ECA-A14A-8E17BF480B7EQ33803185-11C4A080-3F4A-4E1F-BA2B-A65292BA680EQ33982206-C9DE62B9-20AF-46E3-B1A0-38383D0BF6B1Q34024416-40908ED7-8CC4-455E-8A9F-61BCE1A868D8Q34030928-D448F38A-BFBA-41B7-B429-82E29E74F310Q35880502-AC19F123-F953-49E5-8C36-7C7883EEC920Q36321037-5F39605A-C10D-4979-9091-3DDD820A0FB6Q36366992-A1492AF4-5C8F-46E6-8C68-DB95E7538B6AQ36488971-FAB9BD02-AFCE-4789-8997-80836324BD6CQ37215923-B42F6E47-353E-4921-A6BE-1BEE231DA4F6Q37259640-AC17EC65-C66C-409C-8FC8-93C520780D14Q38328870-16EE0711-DC43-4F37-AB25-CA0F52A651F4Q38997873-DBB64B5A-199F-44E3-8B06-C8514D88249FQ39379643-DBDFCABA-B3D0-47BA-A08A-52C9DCF3D893Q40074359-010AE9E6-9400-45C1-BE99-8512E2E65BCAQ47548230-7EC9A579-2F58-4597-9FDF-7A98445C16A1Q53723554-06588728-280D-410B-B890-7F46DE785236Q56912008-67645E6D-B975-4710-A924-E770C2C9AC77
P2860
Long term 5-year survival of persons with cryptococcal meningitis or asymptomatic subclinical antigenemia in Uganda.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Long term 5-year survival of p ...... linical antigenemia in Uganda.
@ast
Long term 5-year survival of p ...... linical antigenemia in Uganda.
@en
Long term 5-year survival of p ...... linical antigenemia in Uganda.
@nl
type
label
Long term 5-year survival of p ...... linical antigenemia in Uganda.
@ast
Long term 5-year survival of p ...... linical antigenemia in Uganda.
@en
Long term 5-year survival of p ...... linical antigenemia in Uganda.
@nl
prefLabel
Long term 5-year survival of p ...... linical antigenemia in Uganda.
@ast
Long term 5-year survival of p ...... linical antigenemia in Uganda.
@en
Long term 5-year survival of p ...... linical antigenemia in Uganda.
@nl
P2860
P50
P1433
P1476
Long term 5-year survival of p ...... linical antigenemia in Uganda.
@en
P2093
Elissa K Butler
P2860
P304
P356
10.1371/JOURNAL.PONE.0051291
P407
P577
2012-12-10T00:00:00Z